Literature DB >> 8194007

Possible role of Helicobacter pylori infection in early gastric cancer development.

M Asaka1, T Kimura, M Kato, M Kudo, K Miki, K Ogoshi, T Kato, M Tatsuta, D Y Graham.   

Abstract

BACKGROUND: Gastric cancer is the most frequently diagnosed malignancy in Japan. The possible relationship between Helicobacter pylori infection and gastric cancer in Japan was evaluated.
METHODS: H. pylori infection was identified by the presence of anti-H. pylori IgG. The frequency of H. pylori infection was compared in 213 patients with gastric cancer and the same number of asymptomatic control subjects matched for age and sex.
RESULTS: The presence of IgG antibody to H. pylori was significantly more prevalent (P < 0.001) in those with gastric cancer compared with asymptomatic control subjects (88.2% versus 74.6%). H. pylori positive rates were significantly greater in patients with the intestinal type (90.4%, P < 0.001) and diffuse type (86.4%, P < 0.05) of gastric cancer than in control subjects. Ninety-three percent of the patients with early gastric cancer tested positive for H. pylori (P < 0.001 compared with control subjects), whereas no significant difference was observed between those with advanced gastric cancer and control subjects. The intestinal type of early gastric cancer showed only the significantly increased frequency of high titer (optical density > 1.50) of H. pylori IgG antibody (P < 0.001) compared with control subjects without cancer.
CONCLUSIONS: These results suggest that H. pylori infection may be associated with the development of early gastric cancer in Japan.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8194007     DOI: 10.1002/1097-0142(19940601)73:11<2691::aid-cncr2820731107>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  50 in total

1.  Analysis of Helicobacter pylori vacA gene and serum antibodies to VacA in Japan.

Authors:  D Shirasaka; N Aoyama; K Satonaka; K Shirakawa; H Yoshida; T Sakai; T Ikemura; Y Shinoda; M Sakashita; M Miyamoto; K Yahiro; A Wada; H Kurazono; T Hirayama; M Kasuga
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

2.  Helicobacter pylori vacA genotypes and cagA status and their relationship to associated diseases.

Authors:  Peng Hou; Zhen-Xing Tu; Guo-Ming Xu; Yan-Fang Gong; Xu-Hui Ji; Zhao-Shen Li
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

3.  Detailed analysis of Helicobacter pylori Fur-regulated promoters reveals a Fur box core sequence and novel Fur-regulated genes.

Authors:  Oscar Q Pich; Beth M Carpenter; Jeremy J Gilbreath; D Scott Merrell
Journal:  Mol Microbiol       Date:  2012-05-14       Impact factor: 3.501

4.  Helicobacter pylori survival in gastric mucosa by generation of a pH gradient.

Authors:  G Chen; R L Fournier; S Varanasi; P A Mahama-Relue
Journal:  Biophys J       Date:  1997-08       Impact factor: 4.033

5.  Gastric cancer screening using the serum pepsinogen test method.

Authors:  Kazumasa Miki
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

Review 6.  Diet, H pylori infection and gastric cancer: evidence and controversies.

Authors:  Alba Rocco; Gerardo Nardone
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

7.  Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.

Authors:  Y Yamaoka; T Kodama; K Kashima; D Y Graham
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

8.  Asymptomatic Helicobacter pylori gastritis is associated with increased sucrose permeability.

Authors:  K Borch; C Sjöstedt; U Hannestad; J D Söderholm; L Franzén; S Mårdh
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

9.  Old and new TNM in carcinoma of the gastric antrum: analysis of our personal experience.

Authors:  Paolo Del Rio; Paolo Dell'Abate; Paolo Soliani; Maria Francesca Arcuri; Sara Tacci; Stefanie Ziegler; Mario Sianesi
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

10.  Does seropositivity for Helicobacter pylori antibodies increase outpatient costs for gastric and duodenal ulcer or inflammation?

Authors:  Akira Babazono; Motonobu Miyazaki; Hiroshi Une; Eiji Yamamoto; Toshihide Tsuda; Yoshio Mino; Alan L Hillman
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.